UBC attracts over $40M to host Networks of Centres of Excellence in nanomedicines
Apr 16, 2019 …
Up-coming presentations by NMIN researchers:
2019 CRS Annual Meeting & Exposition
July 21-24, 2019 | Valencia, Spain
- Christine Allen (NMIN researcher; University of Toronto)
- Pieter Cullis (NMIN Scientific Director & CEO; University of British Columbia)
Vancouver Nanomedicine Day 2019
September 12, 2019 | Vancouver, BC
- Pieter Cullis
(NMIN Scientific Director & CEO; University of British Columbia) - Shana Kelley
(NMIN Diagnostics Theme Leader; University of Toronto)
NMIN Scientific Meeting
September 13-14, 2019 | Vancouver, BC
- Marcel Bally (NMIN Targeted Drug Delivery Theme Leader; University of British Columbia)
- Pieter Cullis (NMIN Scientific Director & CEO; University of British Columbia)
- Shana Kelley (NMIN Diagnostics Theme Leader; University of Toronto)
- Gilbert Walker (NMIN Associate Scientific Director; University of Toronto)
NMIN
about us
Advancing research, innovation and training in nanomedicines to maintain Canada as the world leader in the field.
The NanoMedicines Innovation Network (NMIN) is advancing “smart” medicines to cure disease by delivering small molecule drugs more specifically to disease sites and enabling the clinical use of gene therapies.
NMIN brings 60 Principal Investigators from 17 institutions across Canada together with 15 companies and 8 not-for-profit research and granting institutions in a network committed to expanding and improving Canada’s position as a global leader in nanomedicines R&D.
NMIN is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.
NMIN
Our focus
Develop nanomedicines
that enhance the therapeutic properties of small molecule drugs, and enable gene therapies.
Develop new diagnostics
that enable more precise disease detection and treatment, based on nanotechnology.
Train scientists
in the technology and business of nanomedicines, guided by market needs for HQP with skills required by the R&D community.
Translate nanomedicine
products and technologies, by implementing a cohesive IP and commercialization strategy.
NMIN
Management Team
Pieter Cullis
Scientific Director
Gilbert Walker
Associate Scientific Director
Diana Royce
Executive Director
NMIN
Contact
NMIN
2350 Health Sciences Mall, Room 5451 | University of British Columbia | Vancouver, BC V6T 1Z3 Canada
NMIN
2350 Health Sciences Mall, Room 5451 | University of British Columbia | Vancouver, BC V6T 1Z3 Canada
info@nanomedicines.ca